Main Article Content
of bronchial asthma in adults when added to standard treatment.
Methodology: The study included 80 patients of either gender with age ranging
from 16 to 46 years. Bronchial asthma diagnosed for at least 1 year and
vitamin D levels below 30 ng/ml, no history of smoking, intake of vitamin D 6
months before trial or other chronic diseases were included in the study. They
were randomly divided into two groups by using computer generated random
number table, group A and group B and were given combination of standard
treatment of bronchial asthma and vitamin D vs standard treatment only respectively.
Results: 25(62.5%) were male in group A while 21(52.5%) were male in group
B. Mean age of study population was 29.56 ±8.06 years. Vitamin D was found
more effective in prevention of exacerbations of bronchial asthma (P value
Conclusion: Vitamin D was efficacious in bronchial asthma in terms of prevention
in number of exacerbations when added to standard treatment.
Work published in JPMI is licensed under a
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.